Skip to main content

Table 2 Number of patients and prevalence of multimorbidity

From: Multimorbidity and use of hypnotic and anxiolytic drugs: cross-sectional and follow-up study in primary healthcare in Iceland

Age

groups

All patients contacting the PHCCA

Patients with multimorbidity (number and %)

All

Men

Women

All

%

Men

%

Women

%

<1–19

61,033

30,982

30,051

6,157

10

3,156

10

3,001

10

20–29

34,255

15,950

18,305

8,250

24

3,174

20

5,076

28

30–39

33,291

16,310

16,981

11,077

33

4,480

27

6,597

39

40–49

27,619

13,498

14,121

12,934

47

5,406

40

7,528

53

50–59

25,300

12,398

12,902

14,657

58

6,456

52

8,201

64

60–69

19,159

9,351

9,808

11,955

62

5,578

60

6,377

65

70–79

11,166

5,197

5,969

7,637

68

3,440

66

4,197

70

80+

9,999

4,103

5,896

5,493

55

2,275

55

3,218

55

Total

221,822

107,789

114,033

78,160

35

33,965

32

44,195

39

  1. All patients contacting the Primary Health Care of the Capital Area (PHCCA) during a period of 4 years (1 Jan 2009 to 31 Dec 2012) and prevalence of multimorbidity according to age and sex